Results
|
|
1.
|
Pertuzumab: increasing the options. MedStar authors:
- Nunes, Raquel
- Swain, Sandra M
Citation: - Oncology (Williston Park). 28(3):199, 204, 210, 2014 Mar.
Institution: - Washington Cancer Institute
Medline publication type:
- Comment
- Journal Article
- Research Support, Non-U.S. Gov't
|
|
|
2.
|
Reply to a. Avan et Al. MedStar authors:
Year: 2015
Citation: - Journal of Clinical Oncology. 33(15):1712, 2015 May 20.
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Baselga J, Clark E, Kiermaier A, Swain S
|
|
|
3.
|
Pertuzumab for the treatment of breast cancer. [Review] MedStar authors:
- Lynce, Filipa
- Swain, Sandra M
Year: 2014
Citation: - Cancer Investigation. 32(8):430-8, 2014 Oct.
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Research Support, Non-U.S. Gov't
- Review
|
|
|
4.
|
Foley Catheter as a Vaginal Stent in a Toddler with Vaginal Rhabdomyosarcoma. MedStar authors:
- Fowler, Kylie G
- Gomez-Lobo, Veronica
Year: 2018
Citation: - Journal of Pediatric & Adolescent Gynecology. 31(3):315-317, 2018 Jun.
Institution: - MedStar Washington Hospital Center
Department: - Obstetrics and Gynecology/Pediatric and Adolescent
Medline publication type:
All authors: - Fowler KG, Gomez-Lobo V, Kim A, Mohindra P
|
|
|
5.
|
HALT-D: a randomized open-label phase II study of crofelemer for the prevention of chemotherapy-induced diarrhea in patients with HER2-positive breast cancer receiving trastuzumab, pertuzumab, and a taxane. MedStar authors:
- Kurian, Shweta
- Mohebtash, Mahsa
- Ottaviano, Yvonne
- Rao, Suman
- Swain, Sandra M
Year: 2022
Citation: - Breast Cancer Research & Treatment. 196(3):571-581, 2022 Dec.
Institution: - MedStar Franklin Square Medical Center
Department:
- Associate Dean for Research Development
- Hematology/Oncology
- MedStar Health
Medline publication type:
- Clinical Trial, Phase II
- Journal Article
- Randomized Controlled Trial
All authors: - Dilawari A, Graham D, Isaacs C, Kurian S, Lynce F, Mainor C, McNamara D, Mohebtash M, Ottaviano Y, Pohlmann PR, Rao S, Swain SM, Swanson N, Tan M, Warren R, Wu T
|
|
|
6.
|
Frequency of Takotsubo Cardiomyopathy in Adult Patients Receiving Chemotherapy (from a 5-Year Nationwide Inpatient Study). MedStar authors:
Year: 2019
Citation: - American Journal of Cardiology. 123(4):667-673, 2019 02 15.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Abbas SA, Barac A, Desai R, Durairaj A, Fong HK, Goyal H, Hung O, Kumar G, Sachdeva R, Yusuf SW
|
|
|
7.
|
Determinants of neoadjuvant chemotherapy use in muscle-invasive bladder cancer. MedStar authors:
- Carvalho, Filipe
- Egan, Jillian
- Hwang, Jonathan J
- Krasnow, Ross
- Lynch, John H
- Stamatakis, Lambros
- Zeymo, Alexander
Year: 2020
Citation: - Investigative And Clinical Urology. 61(4):390-396, 2020 07.
Institution:
- MedStar Health Research Institute
- MedStar Washington Hospital Center
Medline publication type:
All authors: - Carvalho FL, Egan J, Hwang J, Kelly CH, Kowalczyk KJ, Krasnow RE, Lynch JH, Stamatakis L, Zeymo A, Zheng C
|
|
|
8.
|
|
|
|
9.
|
Underuse of exon mutational analysis for gastrointestinal stromal tumors. MedStar authors:
- Al-Refaie, Waddah B
- Quadri, Humair S
Year: 2018
Citation: - Journal of Surgical Research. 231:43-48, 2018 Nov.
Institution:
- MedStar Health Research Institute
- MedStar Washington Hospital Center
Medline publication type:
All authors: - Al-Refaie WB, Bartholomew AJ, Dohnalek H, Haddad NG, Marshall JL, O'Neill SC, Prins PA, Quadri HS
|
|
|
10.
|
Assessment of denosumab treatment effects and imaging response in patients with giant cell tumor of bone. MedStar authors:
Year: 2018
Citation: - World Journal of Surgical Oncology. 16(1):191, 2018 Sep 19.
Institution: - MedStar Washington Hospital Center
Medline publication type:
All authors: - Bach BA, Braun A, Chawla S, Choy E, Engellau J, Feng A, Gelderblom H, Grimer R, Henshaw R, Jacobs I, O'Neal M, Reichardt P, Roberts ZJ, Seeger L
|
|
|
11.
|
Breast Cancer and Heart Failure. [Review] MedStar authors:
Year: 2019
Citation: - Heart Failure Clinics. 15(1):65-75, 2019 Jan.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Almuwaqqat Z, Barac A, Meisel JL, Parashar S
|
|
|
12.
|
|
|
|
13.
|
|
|
|
14.
|
Association of Polymorphisms in FCGR2A and FCGR3A With Degree of Trastuzumab Benefit in the Adjuvant Treatment of ERBB2/HER2-Positive Breast Cancer: Analysis of the NSABP B-31 Trial. MedStar authors:
Year: 2017
Citation: - JAMA Oncology. 3(3):335-341, 2017 Mar 01
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
All authors: - Bandos H, Costantino JP, Fehrenbacher L, Finnigan M, Gavin PG, Geyer CE Jr, Jeong JH, Johnson NL, Kim SR, Lipchik C, Mamounas EP, Paik S, Pogue-Geile KL, Rastogi P, Song N, Swain SM, Wickerham DL, Wolmark N
|
|
|
15.
|
|
|
|
16.
|
Biomarker analyses in CLEOPATRA: a phase III, placebo-controlled study of pertuzumab in human epidermal growth factor receptor 2-positive, first-line metastatic breast cancer. MedStar authors:
Year: 2014
Citation: - Journal of Clinical Oncology. 32(33):3753-61, 2014 Nov 20.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Baselga J, Clark E, Cortes J, Im SA, Kiermaier A, Ross G, Swain SM
|
|
|
17.
|
Predicting degree of benefit from adjuvant trastuzumab in NSABP trial B-31. MedStar authors:
Year: 2013
Citation: - Journal of the National Cancer Institute. 105(23):1782-8, 2013 Dec 4.
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - Bandos H, Blackmon NL, Bohn OL, Burandt E, Costantino JP, Fehrenbacher L, Fumagalli D, Gavin PG, Geyer CE Jr, Goldstein LC, Horne ZD, Jeong JH, Kim C, Kim SI, Kim SR, Lee A, Mamounas EP, Paik S, Pogue-Geile KL, Rastogi P, Reilly ML, Remillard MY, Romond EH, Sneige N, Swain SM, Tanaka N, Taniyama Y, Wickerham DL, Wolmark N
|
|
|
18.
|
Vemurafenib-induced DRESS. MedStar authors:
- Jang, Sekwon
- Nasabzadeh, Teresa
- Pichard, Dominique C
- Wenk, Kurt S
Year: 2013
Citation: - JAMA Dermatology. 149(10):1242-3, 2013 Oct.
Institution:
- MedStar Washington Hospital Center
- Washington Cancer Institute
Medline publication type:
- Case Reports
- Journal Article
All authors: - Jang S, Nasabzadeh T, Pichard DC, Venna SS, Wenk KS
|
|
|
19.
|
Health-related quality-of-life assessment in CLEOPATRA, a phase III study combining pertuzumab with trastuzumab and docetaxel in metastatic breast cancer. MedStar authors:
Year: 2013
Citation: - Annals of Oncology. 24(10):2630-5, 2013 Oct.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Baselga J, Clark E, Cortes J, Im SA, Im YH, Knott A, Pivot X, Ross G, Swain SM
|
|
|
20.
|
Implementation of an Enhanced Recovery Protocol Is Associated With On-Time Initiation of Adjuvant Chemotherapy in Colorectal Cancer. MedStar authors:
Year: 2019
Citation: - Diseases of the Colon & Rectum. 62(11):1305-1315, 2019 Nov.
Institution: - MedStar Washington Hospital Center
Department: - Medicine/Internal Medicine
Medline publication type:
All authors: - Bauer-Nilsen K, Friel CM, Hassinger TE, Hedrick TL, Hoang SC, Martin AN, Mehaffey JH, Reilley MJ, Sarosiek BM, Thiele RH, Turrentine FE
|
|
|
21.
|
|
|
|
22.
|
Correlation of Long-term Results of Imatinib in Advanced Gastrointestinal Stromal Tumors With Next-Generation Sequencing Results: Analysis of Phase 3 SWOG Intergroup Trial S0033. MedStar authors:
Year: 2017
Citation:
- JAMA Oncology. , 2017 Feb 09
- JAMA Oncology. 3(7):944-952, 2017 Jul 01
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Baker LH, Benjamin RS, Blackstein ME, Blanke CD, Borden EC, Corless CL, Crowley JJ, Demetri GD, Fletcher JA, Heinrich M, Maki RG, Owzar K, Priebat DA, Rankin C, Ryan CW, Tap WD, von Mehren M
|
|
|
23.
|
Phase 2 clinical trial of sunitinib as adjunctive treatment in patients with advanced differentiated thyroid cancer. MedStar authors:
- Barett, Christina
- Bikas, Athanasios
- Burman, Kenneth D
- Clark, Brandon G
- Desale, Sameer
- Gandhi, Rahul
- Jelinek, James S
- Kundra, Priya
- Mete, Mihriye
- O'Keefe, Kaitlyn
- Wartofsky, Leonard
- Wexler, Jason
- Wray, Lynette
Year: 2016
Citation: - European Journal of Endocrinology. 174(3):373-80, 2016 Mar.
Institution:
- MedStar Health Research Institute
- MedStar Heart & Vascular Institute
- MedStar Washington Hospital Center
Department:
- Medicine/Endocrinology
- Radiology
Medline publication type:
- Clinical Trial, Phase II
- Journal Article
- Research Support, Non-U.S. Gov't
All authors: - Barett C, Bikas A, Burman KD, Clark BG, Desale S, Gandhi R, Jelinek JS, Kundra P, Mete M, O'Keefe K, Wartofsky L, Wexler JA, Wray L
|
